Pacer Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,785,763
Closed -$91.6M 2654
2024
Q2
$91.6M Sell
6,785,763
-561,776
-8% -$11.5M 0.21% 135
2024
Q1
$204M Buy
7,347,539
+2,126,458
+41% +$47.2M 0.47% 55
2023
Q4
$101M Buy
5,221,081
+1,903,266
+57% +$34.5M 0.28% 97
2023
Q3
$53.6M Buy
+3,317,815
New +$58.9M 0.21% 121
2020
Q4
Sell
-28,920
Closed -$726K 1526
2020
Q3
$726K Sell
28,920
-31,148
-52% -$454K 0.02% 852
2020
Q2
$458K Buy
+60,068
New +$440K 0.01% 727
2018
Q1
Sell
-14,796
Closed -$279K 1099
2017
Q4
$279K Buy
14,796
+7,639
+107% +$169K 0.02% 872
2017
Q3
$209K Hold
7,157
0.02% 1002
2017
Q2
$230K Sell
7,157
-26
-0.4% -$853 0.02% 943
2017
Q1
$249K Hold
7,183
0.03% 833
2016
Q4
$253K Buy
+7,183
New +$243K 0.04% 770

Other funds holding ACH

Pacer Advisors's ACH Position: Q3 2024 in Review

Pacer Advisors sold out of Accendra Health (ACH) in Q3 2024, closing a stake of 6,785,763 shares — an estimated $91.6M sold.

Pacer Advisors first reported a position in ACH in Q4 2016 and held it in 11 quarters. The position peaked at $204M in Q1 2024. 213 funds tracked by Wall St. Rank hold ACH as of Q3 2024.

  • Pacer Advisors reported no remaining Accendra Health position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 6,785,763 Accendra Health shares in Q3 2024, an estimated $91.6M.
  • Pacer Advisors first reported a position in Accendra Health in Q4 2016 and held it in 11 quarters.
  • Pacer Advisors's Accendra Health position peaked at $204M in Q1 2024.
  • 213 funds tracked by Wall St. Rank held Accendra Health as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.